Anbio Biotechnology (NNNN) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: April 28, 2025

Risk Assessment Details

Potential Dilution: 3.78% of current shares

Recent Dilution: 0.0% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

42M

Potential Supply

1.6M

Additional shares possible

Splits

None

Past 2 years

Summary

NNNN currently has 42.3M outstanding shares. with limited dilution risk as only 1.6M additional shares (3.8%) are authorized for issuance. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
Apr 28, 2025	20-F filing \| 42.3M shares outstanding	42M	1.6M
Dec 31, 2024	F-1 filing: This F-1 filing indicates an offering of Class A Ordinary Shares, with a proposed offering amount of approximately $8,000,000 based on an estimated price of $5.00 per share. The company intends to use the net proceeds of this offering primarily for expansion of sales and distribution network in the strategically selected markets, research and development, and working capital and general corporate matters.	42M	1.6M

Back to NNNN Details